BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 30945144)

  • 21. Novel miRNAs as potential biomarkers in stage II colon cancer: microarray analysis.
    Gungormez C; Gumushan Aktas H; Dilsiz N; Borazan E
    Mol Biol Rep; 2019 Aug; 46(4):4175-4183. PubMed ID: 31123908
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicroRNA miR-107 is overexpressed in pituitary adenomas and inhibits the expression of aryl hydrocarbon receptor-interacting protein in vitro.
    Trivellin G; Butz H; Delhove J; Igreja S; Chahal HS; Zivkovic V; McKay T; Patócs A; Grossman AB; Korbonits M
    Am J Physiol Endocrinol Metab; 2012 Sep; 303(6):E708-19. PubMed ID: 22811466
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of microRNA (miRNA) expression profiles reveals 11 key biomarkers associated with non-small cell lung cancer.
    Wang K; Chen M; Wu W
    World J Surg Oncol; 2017 Sep; 15(1):175. PubMed ID: 28927412
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of Tumor-Derived Exosomal miRNA as Potential Diagnostic Biomarkers for Early-Stage Non-Small Cell Lung Cancer Using Next-Generation Sequencing.
    Jin X; Chen Y; Chen H; Fei S; Chen D; Cai X; Liu L; Lin B; Su H; Zhao L; Su M; Pan H; Shen L; Xie D; Xie C
    Clin Cancer Res; 2017 Sep; 23(17):5311-5319. PubMed ID: 28606918
    [No Abstract]   [Full Text] [Related]  

  • 25. Downregulation of miR-410 targeting the cyclin B1 gene plays a role in pituitary gonadotroph tumors.
    Müssnich P; Raverot G; Jaffrain-Rea ML; Fraggetta F; Wierinckx A; Trouillas J; Fusco A; D'Angelo D
    Cell Cycle; 2015; 14(16):2590-7. PubMed ID: 26125663
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Upregulated microRNAs in membranous glomerulonephropathy are associated with significant downregulation of IL6 and MYC mRNAs.
    Barbagallo C; Passanisi R; Mirabella F; Cirnigliaro M; Costanzo A; Lauretta G; Barbagallo D; Bianchi C; Pagni F; Castorina S; Granata A; Di Pietro C; Ragusa M; Malatino LS; Purrello M
    J Cell Physiol; 2019 Aug; 234(8):12625-12636. PubMed ID: 30515781
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNA expression profiling analysis in serum for nasopharyngeal carcinoma diagnosis.
    Zou X; Zhu D; Zhang H; Zhang S; Zhou X; He X; Zhu J; Zhu W
    Gene; 2020 Feb; 727():144243. PubMed ID: 31743768
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Downregulation of miR-216a-5p and miR-652-3p is associated with growth and invasion by targeting JAK2 and PRRX1 in GH-producing pituitary tumours.
    Lee YJ; Kang CW; Oh JH; Kim J; Park JP; Moon JH; Kim EH; Lee S; Kim SH; Ku CR; Lee EJ
    J Mol Endocrinol; 2021 Nov; 68(1):51-62. PubMed ID: 34738916
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNA Expression Profiling in Clear Cell Renal Cell Carcinoma: Identification and Functional Validation of Key miRNAs.
    He H; Wang L; Zhou W; Zhang Z; Wang L; Xu S; Wang D; Dong J; Tang C; Tang H; Yi X; Ge J
    PLoS One; 2015; 10(5):e0125672. PubMed ID: 25938468
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Profiling of downregulated blood-circulating miR-150-5p as a novel tumor marker for cholangiocarcinoma.
    Wu X; Xia M; Chen D; Wu F; Lv Z; Zhan Q; Jiao Y; Wang W; Chen G; An F
    Tumour Biol; 2016 Nov; 37(11):15019-15029. PubMed ID: 27658773
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNA Expression Profiling in Adrenal Myelolipoma.
    Decmann A; Perge P; Nyíro G; Darvasi O; Likó I; Borka K; Micsik T; Tóth Z; Bancos I; Pezzani R; Iacobone M; Patócs A; Igaz P
    J Clin Endocrinol Metab; 2018 Sep; 103(9):3522-3530. PubMed ID: 29982598
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Up-regulation of the expressions of MiR-149-5p and MiR-99a-3p in exosome inhibits the progress of pituitary adenomas.
    Zhao P; Cheng J; Li B; Nie D; Li C; Gui S; Wang H; Zhang Y
    Cell Biol Toxicol; 2021 Aug; 37(4):633-651. PubMed ID: 33400021
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CBX1 is a direct target of miR-205-5p and contributes to the progression of pituitary tumor.
    Hu A; Zhang Y; Zhao X; Li J; Ying Y
    Pharmazie; 2019 Mar; 74(3):154-156. PubMed ID: 30961681
    [TBL] [Abstract][Full Text] [Related]  

  • 34. miRNA profiles of canine cutaneous mast cell tumours with early nodal metastasis and evaluation as potential biomarkers.
    Zamarian V; Ferrari R; Stefanello D; Ceciliani F; Grieco V; Minozzi G; Chiti LE; Arigoni M; Calogero R; Lecchi C
    Sci Rep; 2020 Nov; 10(1):18918. PubMed ID: 33144602
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Down-regulation of Wee1 kinase by a specific subset of microRNA in human sporadic pituitary adenomas.
    Butz H; Likó I; Czirják S; Igaz P; Khan MM; Zivkovic V; Bálint K; Korbonits M; Rácz K; Patócs A
    J Clin Endocrinol Metab; 2010 Oct; 95(10):E181-91. PubMed ID: 20668041
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exploring the miRNA-mRNA regulatory network in clear cell renal cell carcinomas by next-generation sequencing expression profiles.
    Müller S; Nowak K
    Biomed Res Int; 2014; 2014():948408. PubMed ID: 24977165
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 3D Cell Culture-Based Global miRNA Expression Analysis Reveals miR-142-5p as a Theranostic Biomarker of Rectal Cancer Following Neoadjuvant Long-Course Treatment.
    Kunigenas L; Stankevicius V; Dulskas A; Budginaite E; Alzbutas G; Stratilatovas E; Cordes N; Suziedelis K
    Biomolecules; 2020 Apr; 10(4):. PubMed ID: 32316138
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MicroRNA-106b promotes pituitary tumor cell proliferation and invasion through PI3K/AKT signaling pathway by targeting PTEN.
    Zhou K; Zhang T; Fan Y; Serick ; Du G; Wu P; Geng D
    Tumour Biol; 2016 Oct; 37(10):13469-13477. PubMed ID: 27465551
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Deep sequencing-based microRNA expression signatures in head and neck squamous cell carcinoma: dual strands of pre-miR-150 as antitumor miRNAs.
    Koshizuka K; Nohata N; Hanazawa T; Kikkawa N; Arai T; Okato A; Fukumoto I; Katada K; Okamoto Y; Seki N
    Oncotarget; 2017 May; 8(18):30288-30304. PubMed ID: 28415821
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNA involvement in a metastatic non-functioning pituitary carcinoma.
    Wei Z; Zhou C; Liu M; Yao Y; Sun J; Xiao J; Ma W; Zhu H; Wang R
    Pituitary; 2015 Oct; 18(5):710-21. PubMed ID: 25862551
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.